gwb | Grubman Warner Berry

DOJ

The Rebirth of the DOJ’s False Claims Act Working Group

While much of the Department of Justice’s (DOJ) enforcement has shifted away from white collar to other areas such as immigration, drug trafficking, and violent crime, the Trump DOJ has made clear that it will continue to prioritize enforcement under the False Claims Act (FCA), using both traditional theories of liability and some that are […]

Read More

DOJ Criminal Chief Issues Sweeping Memo Regarding White Collar Criminal Enforcement

On May 12, 2025, Matthew Galeotti, who heads the Department of Justice’s (DOJ) criminal division, released a memo addressed to all criminal division personnel entitled “Focus, Fairness, and Efficiency in the Fight Against White-Collar Crime.” Galeotti begins his memo by stating that “white-collar crime [] poses a significant risk to U.S. interests,” and that “the […]

Read More
Trump Moves to Delay Medicare Drug Pricing

Florida Research Facility Owners Plead in Clinical Trial Fraud Case

           On March 10, 2025, the Department of Justice (DOJ) announced that two owners of a Florida-based clinical research facility pleaded guilty to conspiracy to commit wire fraud in connection with asthma drug trials.            According to the DOJ, Angela Baquero, 49, and Ricardo Acuna, 52, operated […]

Read More

DOJ Announce Largest Forfeiture in the Department’s History

The DOJ has announced its largest forfeiture in the history of the Department of Justice’s Health Care Fraud Unit. A Texas pharmacist, Dehshid “David” Nourian, has been sentenced to over 17 years in prison and ordered to forfeit $405 million in assets for orchestrating a massive healthcare fraud scheme.  According to the DOJ, Nourian, along […]

Read More

Get in Touch With Us

For more information or to arrange a consultation, please contact us by telephone at (404) 233-4171 or online by submitting the form below. The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship nor create an expectancy of a potential attorney-client relationship. Do not submit information which is confidential or time sensitive, as it may not be treated as such.